The goal of this clinical trial is to determine whether participation in an individual 8-session cognitive processing therapy (CPT) is feasible, acceptable, and leads to clinically meaningful trauma symptom reduction in individuals experiencing childbirth-related trauma. The main questions it aims to answer are: 1. Is it feasible for women and birthing people to attend and complete an 8-session course of CPT delivered virtually within a specialized women's mental health clinic? 2. Do participants find this modified 8-session CPT protocol acceptable and helpful? 3. Does the treatment lead to clinically meaningful reductions in childbirth-related posttraumatic stress and related symptoms? Participants will be asked to: 1. Attend 8 weekly sessions of individual CPT for childbirth-related trauma 2. Complete a self-report measure of trauma symptoms weekly (i.e., the PCL-5) 3. Complete additional symptom questionnaires at baseline, post-treatment, and at one-month follow-up. 4. Complete a brief qualitative interview one week after treatment to share feedback on their experience
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Feasibility: Recruitment Rate
Timeframe: Measured through the recruitment period (up to 12 months)
Feasibility: Eligibility Rate
Timeframe: Measured through the recruitment period (up to 12 months)
Feasibility: Session Attendance
Timeframe: Measured during the treatment period, from the first to last session (up to 8 weeks)
Feasibility: Homework Completion
Timeframe: Measured during the treatment period, from the first to last session (up to 8 weeks)
Feasibility: Treatment Completion Rate
Timeframe: Measured at the end of treatment (8 weeks)
Feasibility: Retention Rate
Timeframe: Measured at baseline (at enrolment, 0 weeks), post-treatment (8 weeks), and one-month follow-up (12 weeks)
Acceptability: measured using a Brief Qualitative Interview
Timeframe: Administered one week after finishing the treatment
Acceptability: measured using the Client Satisfaction Questionnaire (CSQ)
Timeframe: Administered at post-treatment (immediately after the 8-week intervention)